Department of Otolaryngology/Head and Neck Surgery, Aintree University Hospital NHS Foundation Trust, Liverpool, United Kingdom.
Head Neck. 2009 Dec;31(12):1563-70. doi: 10.1002/hed.21124.
Screening for synchronous pulmonary tumors in patients presenting with squamous cell carcinoma of the head and neck (SCCHN) is important, because detection may alter subsequent management.
We conducted a retrospective review, comparing effectiveness of pulmonary screening using thoracic CT or chest X-ray, in 1882 patients presenting with SCCHN.
The overall rate of synchronous pulmonary tumors was 4.3%. The number needed to scan, ie, the number of thoracic CTs required to detect 1 pulmonary tumor, is reported for recurrent primary tumors, primary disease load (T and N classification), and individual primary sites. The incidence of pulmonary metastases is related to locoregional disease load while the incidence of bronchogenic carcinoma is sporadic.
Although it is possible to propose a pragmatic screening protocol for pulmonary metastases, this is not possible for bronchogenic carcinomas. Therefore, we recommend that thoracic CT is used in all cases to screen for coexistent pulmonary pathology.
在头颈部鳞状细胞癌(SCCHN)患者中筛查同时性肺肿瘤很重要,因为检出可能会改变后续的治疗方案。
我们对 1882 例 SCCHN 患者进行了回顾性研究,比较了使用胸部 CT 或胸部 X 线进行肺部筛查的效果。
总的同时性肺肿瘤发生率为 4.3%。为了检测 1 个肺肿瘤,需要扫描的次数(即需要进行的胸部 CT 次数)因复发性原发性肿瘤、原发性疾病负荷(T 和 N 分类)和原发性肿瘤部位的不同而有所不同。肺转移的发生率与局部区域疾病负荷有关,而支气管癌的发生率则是散发性的。
虽然有可能为肺转移提出一种实用的筛查方案,但对于支气管癌则无法做到这一点。因此,我们建议对所有病例均使用胸部 CT 来筛查并存的肺部病变。